Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC03089 (long intergenic non-protein coding RNA 3089), also known as RP11-20J15.2, is a member of the long intergenic non-coding RNA (lincRNA) family. LincRNAs are non-coding RNAs greater than 200 nucleotides that do not overlap protein-coding genes and are often involved in gene regulation, including chromatin remodeling and transcriptional modulation[1][5]. There is currently little or no experimentally validated biological function or disease relevance specifically attributed to LINC03089; while related lincRNAs in general are increasingly recognized as contributors to gene regulation and disease, the specific function and potential disease association of LINC03089 remain unexplored[3][1][5]. No drugs, clinical biomarkers, or safety concerns associated with this lincRNA have been identified.
Not applicable (no drugs known to target this lincRNA; mechanisms for lincRNAs generally involve modulation of gene expression or chromatin state)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3089 (LINC03089).